Quality of Life Following Thrombectomy for Acute Ischemic Stroke

A patient-reported quality-of-life tool provided a granular assessment of outcomes in a single-center study.

Previous trials evaluating the utility of endovascular thrombectomy for acute ischemic stroke have primarily focused on achieving functional independence. The modified Rankin Scale (mRS) is the most commonly used tool to rate this outcome. But there are other instruments available to assess quality of life that can provide a more granular view of patient outcomes.

Now, investigators in Germany have conducted a single-center, prospective, observational study to analyze health-related quality of life (HRQoL) after thrombectomy in 504 consecutive stroke patients (median age, 76 years) using the EuroQoL Group 5-Dimension (EQ-5D) patient-report questionnaire. The researchers also sought to correlate the results with mRS scores and identify predic…

Reviewing Author

Seemant Chaturvedi, MD

Disclosures

Consultant/Advisory BoardBayer Pharmaceuticals; Novartis

Grant/Research SupportNational Institute of Neurological Disorders and Stroke

Editorial BoardsNeurology; Stroke

Seemant Chaturvedi, MD

Disclosures

Consultant/Advisory BoardBayer Pharmaceuticals; Novartis

Grant/Research SupportNational Institute of Neurological Disorders and Stroke

Editorial BoardsNeurology; Stroke

Quality of Life Following Thrombectomy for Acute Ischemic Stroke

Topics

Reviewing Author